Literature DB >> 23324872

Life course study of the etiology of self-reported irritable bowel syndrome in the 1958 British birth cohort.

Laura Goodwin1, Peter D White, Matthew Hotopf, Stephen A Stansfeld, Charlotte Clark.   

Abstract

OBJECTIVE: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with unknown etiology. This is the first study to use a life course approach to examine premorbid risk markers for self-reported IBS in a UK birth cohort.
METHODS: Cohort study using the 1958 British birth cohort, which included 98.7% of births in 1 week in England, Wales, and Scotland. The outcome was self-reported IBS by the age of 42 years, classified with onset after 24 years and onset after 34 years. Childhood psychopathology was assessed by the Rutter scales, and adulthood psychopathology was assessed by the Malaise Inventory.
RESULTS: The prevalence of self-reported IBS in this cohort was 8.4% by 42 years (95% confidence interval [CI]=8.2-8.6). In multivariate analyses, being female (odds ratio [OR]=2.00, 95% CI=1.67-2.36), reporting 1 week to 1 month of school absence for ill health at 16 years (OR=1.27, 95% CI=1.03-1.56) and psychopathology at 23 years (OR=1.25, 95% CI=1.01-1.54) and 33 years (OR=2.20, 95% CI=1.74-2.76) were associated with an increased odds for IBS. Prospectively measured childhood adversity showed no significant association.
CONCLUSIONS: This is the first study to show a long-term prospective link between premorbid psychopathology and later self-reported IBS, in agreement with previous findings on chronic fatigue syndrome. There is no evidence that prospective measures of childhood adversity are risk markers for IBS, and there is weak evidence that prospective measures of childhood illness at 16 years are risk markers for IBS, differing to results from the same cohort for psychopathology, chronic fatigue syndrome, and chronic widespread pain. This study also does not replicate the findings of retrospective studies examining the etiology of IBS.

Entities:  

Mesh:

Year:  2013        PMID: 23324872     DOI: 10.1097/PSY.0b013e31827c351b

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  7 in total

Review 1.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

2.  Prevalence and impact of self-reported irritable bowel symptoms in the general population.

Authors:  K Van den Houte; F Carbone; J Pannemans; M Corsetti; B Fischler; H Piessevaux; J Tack
Journal:  United European Gastroenterol J       Date:  2018-12-22       Impact factor: 4.623

3.  The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.

Authors:  Bernd Löwe; Ansgar Lohse; Viola Andresen; Eik Vettorazzi; Matthias Rose; Wiebke Broicher
Journal:  Am J Gastroenterol       Date:  2016-07-05       Impact factor: 10.864

Review 4.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Nora Hamdani; Wahid Boukouaci; Aroldo Dargel; José Oliveira; Matthieu Roger; Ryad Tamouza; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-06       Impact factor: 5.270

5.  Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity.

Authors:  Paul Enck; Jochen Hefner; Beate M Herbert; Nazar Mazurak; Katja Weimer; Eric R Muth; Stephan Zipfel; Ute Martens
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

6.  Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study.

Authors:  Francis Creed
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 7.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.